|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.68 SEK | +0.41% |
|
-9.72% | -12.92% |
| Market Cap | 1.05B 109M 94.95M 87.62M 80.76M 152M 10.46B 156M 412M 5.12B 408M 399M 17.64B | P/E 2026 * |
-13.2x | P/E 2027 * | -25.9x |
|---|---|---|---|---|---|
| Enterprise Value | 1.03B 107M 93.37M 86.16M 79.41M 150M 10.29B 153M 405M 5.04B 401M 392M 17.35B | EV / Sales 2026 * |
7.42x | EV / Sales 2027 * | 50.7x |
| Free-Float |
70.28% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: SynAct Pharma AB
| 1 day | +0.41% | ||
| 1 week | -9.72% | ||
| Current month | -6.51% | ||
| 1 month | +68.78% | ||
| 3 months | +15.09% | ||
| 6 months | -17.31% | ||
| Current year | -12.92% |
| 1 week | 19.38 |  | 21.9 |
| 1 month | 12.36 | | 23.5 |
| Current year | 7.05 | | 24.4 |
| 1 year | 7.05 | | 25.3 |
| 3 years | 4.98 | | 124.6 |
| 5 years | 4.98 | | 146 |
| 10 years | 4.78 | | 146 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jeppe Øvlesen
CEO | Chief Executive Officer | 64 | 01/01/2014 |
Ann Kristin Led
DFI | Director of Finance/CFO | - | 01/03/2026 |
Kirsten Harting
CTO | Chief Tech/Sci/R&D Officer | - | 15/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Jeppe Øvlesen
BRD | Director/Board Member | 64 | 20/03/2024 |
Anders Kronborg
CHM | Chairman | 62 | 20/03/2024 |
Sten Scheibye
BRD | Director/Board Member | 74 | 20/03/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 10/3/26 | Buy | Chairman | 2,750 | 0.0052% | ||
| 9/3/26 | Buy | Executive/Senior Manager | 1,500 | 0.0028% | ||
| 9/3/26 | Quantass ApS
| Buy | Company | 7,900 | 0.0148% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.41% | -9.72% | -9.72% | -78.44% | 109M | |
| +0.85% | -0.80% | +52.79% | +161.33% | 1,051B | |
| +1.23% | -1.53% | +54.58% | +59.08% | 609B | |
| +0.04% | +2.58% | +34.47% | +86.33% | 450B | |
| +0.78% | -0.71% | +29.28% | +24.10% | 330B | |
| +1.41% | +0.58% | +35.44% | +40.67% | 284B | |
| -0.27% | -1.87% | +22.34% | +22.51% | 263B | |
| -1.76% | +2.37% | -20.43% | -38.00% | 223B | |
| -1.42% | +0.80% | +24.27% | +57.50% | 198B | |
| -1.48% | +3.43% | +24.08% | +71.67% | 167B | |
| Average | -0.02% | -0.49% | +24.71% | +40.67% | 357.52B | |
| Weighted average by Cap. | +0.37% | +0.02% | +37.51% | +79.62% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 139M 14.4M 12.58M 11.61M 10.7M 20.17M 1.39B 20.62M 54.57M 679M 54.06M 52.87M 2.34B | 21.15M 2.19M 1.92M 1.77M 1.63M 3.07M 211M 3.14M 8.32M 103M 8.24M 8.06M 356M |
| Net income | 52.18M 5.41M 4.73M 4.37M 4.02M 7.58M 521M 7.75M 20.52M 255M 20.33M 19.88M 879M | -26.04M -2.7M -2.36M -2.18M -2.01M -3.79M -260M -3.87M -10.24M -127M -10.15M -9.93M -439M |
| Net Debt | -17.48M -1.81M -1.58M -1.46M -1.35M -2.54M -175M -2.6M -6.88M -85.53M -6.81M -6.66M -294M | 24.86M 2.58M 2.25M 2.08M 1.92M 3.61M 248M 3.69M 9.78M 122M 9.69M 9.47M 419M |
Employees
8
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/07/26 | SEK 19.68 | +0.41% | 130,856 |
| 16/07/26 | SEK 19.60 | +0.41% | 105,576 |
| 15/07/26 | SEK 19.52 | -2.89% | 127,568 |
| 14/07/26 | SEK 20.10 | -4.74% | 134,541 |
| 13/07/26 | SEK 21.10 | -3.21% | 205,728 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SYNACT Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
